Saudi Arabia is set to play a key role in the development of a Russian COVID-19 vaccine that produced promising results in the first phase of human trials.
The monthlong trial on 38 people ended this week, and a 100-person Phase II trial is under way.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), said...
Russian Coronavirus Vaccine Trials To Be Held In Saudi Arabia
Eurasia Review
0 shares
1 views
You might like
Related news coverage
Beijing’s Soft Diplomacy In West Asia In Times Of COVID-19 – Analysis
By Nagapushpa Devendra*
The coronavirus disease (COVID-19) that emerged from Wuhan in China in December 2019 has..
Eurasia Review